These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19804822)

  • 1. The influence of drug-drug interaction and patients' characteristics on valproic acid's clearance in adults with epilepsy using nonlinear mixed effects modeling.
    Vucićević K; Miljković B; Pokrajac M; Prostran M; Martinović Z; Grabnar I
    Eur J Pharm Sci; 2009 Dec; 38(5):512-8. PubMed ID: 19804822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic model of carbamazepine derived from routine therapeutic drug monitoring data.
    Vucićević K; Miljković B; Velicković R; Pokrajac M; Mrhar A; Grabnar I
    Ther Drug Monit; 2007 Dec; 29(6):781-8. PubMed ID: 18043476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of valproate in Mexican children with epilepsy.
    Correa T; Rodríguez I; Romano S
    Biopharm Drug Dispos; 2008 Dec; 29(9):511-20. PubMed ID: 19067436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.
    Dutta S; Faught E; Limdi NA
    J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of valproic acid concentrations in elderly nursing home residents.
    Birnbaum AK; Ahn JE; Brundage RC; Hardie NA; Conway JM; Leppik IE
    Ther Drug Monit; 2007 Oct; 29(5):571-5. PubMed ID: 17898646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy.
    Rivas N; Buelga DS; Elger CE; Santos-Borbujo J; Otero MJ; Domínguez-Gil A; García MJ
    Ther Drug Monit; 2008 Aug; 30(4):483-9. PubMed ID: 18641550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of topiramate in adult patients with epilepsy using nonlinear mixed effects modelling.
    Jovanović M; Sokić D; Grabnar I; Vovk T; Prostran M; Vučićević K; Miljković B
    Eur J Pharm Sci; 2013 Nov; 50(3-4):282-9. PubMed ID: 23891703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication.
    May TW; Boor R; Rambeck B; Jürgens U; Korn-Merker E; Brandt C
    Ther Drug Monit; 2011 Apr; 33(2):214-21. PubMed ID: 21383651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
    Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
    Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children.
    Ueshima S; Aiba T; Makita T; Nishihara S; Kitamura Y; Kurosaki Y; Kawasaki H; Sendo T; Ohtsuka Y; Gomita Y
    J Clin Pharm Ther; 2008 Feb; 33(1):31-8. PubMed ID: 18211614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of valproate in Chinese children with epilepsy.
    Jiang DC; Wang L; Wang YQ; Li L; Lu W; Bai XR
    Acta Pharmacol Sin; 2007 Oct; 28(10):1677-84. PubMed ID: 17883957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlinear mixed effects modelling approach in investigating phenobarbital pharmacokinetic interactions in epileptic patients.
    Vučićević K; Jovanović M; Golubović B; Kovačević SV; Miljković B; Martinović Ž; Prostran M
    Eur J Clin Pharmacol; 2015 Feb; 71(2):183-90. PubMed ID: 25380628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of dosage of sustained-release formulation on valproate clearance and plasma concentration in psychiatric patients: analysis based on routine therapeutic drug monitoring data.
    Sriboonruang T; Panomvana D; Chamchitchun S; Silpakit O
    J Clin Psychopharmacol; 2011 Feb; 31(1):115-9. PubMed ID: 21192154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.